PHARMACOKINETIC/PHARMACODYNAMIC ANALYSIS OF HUMAN ANTI-C1S ANTIBODY (TNT009) AND CLASSICAL COMPLEMENT PATHWAY (CP) ACTIVITY

被引：0
|
作者：
Jilma, B. [1 ]
Gilbert, J. [2 ]
Nix, D. [2 ]
Chang, C. [3 ]
Beliveau, M. [3 ]
Marier, J. [3 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] True North Therapeut Inc, San Francisco, CA USA
[3] Certara Strateg Consulting, Montreal, PQ, Canada
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2017年 / 101卷 / S1期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-018
引用
收藏
页码：S58 / S58
页数：1
相关论文
共 33 条
  • [1] PHARMACOKINETIC MODELING AND SIMULATIONS OF HUMAN ANTI-C1S ANTIBODY (TNT009) IN NORMAL HUMAN VOLUNTEERS AND PATIENTS WITH COMPLEMENT-MEDIATED DISORDERS.
    Jilma, B.
    Gilbert, J.
    Nix, D.
    Chang, C.
    Beliveau, M.
    Marier, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S58 - S58
  • [2] EFFECT OF THE ANTI-C1S HUMANIZED ANTIBODY TNT009 AND ITS PARENTAL MOUSE VARIANT TNT003 ON HLA ANTIBODY-INDUCED COMPLEMENT ACTIVATION - A PRECLINICAL IN VITRO STUDY
    Wahrmann, Markus
    Muehlbacher, Jakob
    Marinova, Lena
    Regele, Heinz
    Huttary, Nicole
    Eskandary, Farsad
    Cohen, Gerald
    Fischer, Gottfried F.
    Parry, Graham C.
    Gilbert, James C.
    Panicker, Sandip
    Boehmig, Georg A.
    HLA, 2017, 89 (06) : 342 - 342
  • [3] Effect of the Anti-C1s Humanized Antibody TNT009 and Its Parental Mouse Variant TNT003 on HLA Antibody-Induced Complement Activation-A Preclinical In Vitro Study
    Wahrmann, M.
    Muehlbacher, J.
    Marinova, L.
    Regele, H.
    Huttary, N.
    Eskandary, F.
    Cohen, G.
    Fischer, G. F.
    Parry, G. C.
    Gilbert, J. C.
    Panicker, S.
    Boehmig, G. A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (09) : 2300 - 2311
  • [4] Safety and Activity of Anti-C1s Humanized Monoclonal Antibody TNT009 in Late Antibody-Mediated Kidney Allograft Rejection - Results of a First-in-Human Phase 1 Trial
    Eskandary, F.
    Jilma, B.
    Muehlbacher, J.
    Wahrmann, M.
    Regele, H.
    Kozakowski, N.
    Panicker, S.
    Reeve, J.
    Halloran, P.
    Gilbert, J.
    Bohmig, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 309 - 309
  • [5] SAFETY AND ACTIVITY OF ANTI-C1S HUMANIZED MONOCLONAL ANTIBODY TNT009 IN LATE ANTIBODY-MEDIATED KIDNEY ALLOGRAFT REJECTION - RESULTS OF A FIRST-IN-HUMAN PHASE 1 TRIAL
    Eskandary, Farsad
    Jilma, Bernd
    Muehlbacher, Jakob
    Wahrmann, Markus
    Regele, Heinz
    Kozakowski, Nicolas
    Panicker, Sandip
    Reeve, Jeff
    Halloran, Philip F.
    Gilbert, James C.
    Boehmig, Georg A.
    TRANSPLANT INTERNATIONAL, 2017, 30 : 113 - 113
  • [6] MULTIPLE DOSING OF ANTI-C1S ANTIBODY TNT009 EFFECT ON HLA ANTIBODY-TRIGGERED COMPLEMENT ACTIVATION IN HEALTHY VOLUNTEERS AND KIDNEY TRANSPLANT RECIPIENTS WITH ANTIBODY-MEDIATED REJECTION
    Muehlbacher, J.
    Jilma, B.
    Wahrmann, M.
    Eskandary, F.
    Gilbert, James. C.
    Panicker, S.
    Boehmig, G.
    TRANSPLANT INTERNATIONAL, 2017, 30 : 13 - 13
  • [7] THE ANTI C1S COMPLEMENT ANTIBODY TNT009 INDUCES RAPID COMPLETE REMISSIONS OF ANAEMIA IN PATIENTS WITH PRIMARY COLD AGGLUTININ DISEASE
    Jaeger, U.
    Gilbert, J. C.
    Panicker, S.
    Parry, G. C.
    Fillitz, M.
    Schenk, T.
    Sillaber, C.
    Bartko, J.
    Jilma, B.
    HAEMATOLOGICA, 2016, 101 : 341 - 341
  • [8] Characterization of a novel anti-C1s clone inhibiting the classical complement pathway
    Fagerang, Beatrice
    Lau, Corinna
    Christiansen, Dorte
    Schjalm, Camilla
    Willems, Loek
    Garred, Peter
    Nilsson, Per
    Mollnes, Tom Eirik
    MOLECULAR IMMUNOLOGY, 2022, 141 : 144 - 145
  • [9] BLOCKADE OF HLA ANTIBODY-TRIGGERED CLASSICAL COMPLEMENT ACTIVATION BY HIGH-AFFINITY HUMANIZED MONOCLONAL ANTI-C1S ANTIBODY TNT009-RESULTS OF A PHASE 1 TRIAL
    Muehlbacher, J.
    Jilma, B.
    Wahrmann, M.
    Marinova, L.
    Eskandary, F.
    Gilbert, J. C.
    Panicker, S.
    Boehmig, G. A.
    TRANSPLANT INTERNATIONAL, 2016, 29 : 10 - 10
  • [10] TNT009 and Its Parental Mouse Monoclonal Antibody TNT003 Target Complement Component C1s and Effectively Block Alloantibody-Induced Classical Complement Pathway Activation - The Preclinical Experience.
    Wahrmann, M.
    Muehlbacher, J.
    Regele, H.
    Eskandary, F.
    Gilbert, J.
    Panicker, S.
    Boehmig, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 720 - 720
1234